IP Library Patent Application 18536798
Patent Application
App. No. 18/536,798

METHOD FOR IMPLANTING A CARDIOVASCULAR VALVE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/536,798
Abstract

A method is provided for implanting a valve having at least one valve leaflet within the cardiovascular system of a subject. One step of the method includes preparing a substantially dehydrated bioprosthetic valve and then providing an expandable support member having oppositely disposed first and second ends and a main body portion extending between the ends. Next, the substantially dehydrated bioprosthetic valve is attached to the expandable support member so that the substantially dehydrated bioprosthetic valve is operably secured within the main body portion of the expandable support member. The expandable support member is then crimped into a compressed configuration and placed at a desired location within the cardiovascular system of the subject. Either before or after placement at the desired location, fluid, or blood re-hydrates the substantially dehydrated bioprosthetic valve.

Claims (17)

1 . A method to implant a prosthetic heart valve stored in a liquid free package comprising:

removing the prosthetic valve from a sealed package essentially free of liquid;

implanting the prosthetic heart valve prosthetic valve within a native annulus;

wherein the prosthetic valve in the liquid free package comprises an annular expandable support member having a compressed and an expanded configuration and at least two strut members spaced apart from each other and affixed at the commissural section of a valve component such that adjacent commissural sections are attached to one of the strut members, wherein the annular expandable support member is comprised of a stent and oppositely disposed first and second ends and a main body portion extending therebetween secured to the valve component at the at least two strut members, a layer of synthetic biocompatible material wrapped around an inner and an outer circumference of the annular expandable support member, and wherein the valve component is animal tissue having a surface comprised of interstices comprised of at least one dimensional stabilizer,

and wherein the implanting step comprises expanding the annular expandable support member to engage the native annulus.

2 . The method of claim 1 , wherein the packaged device further comprises a delivery catheter and the implanting step comprises manipulating the delivery catheter to place the prosthetic heart valve within the native annulus.

3 . The method of claim 2 , wherein the prosthetic heart valve is crimped about the periphery of a distal end of the delivery catheter.

4 . The method of claim 2 , wherein the prosthetic heart valve is operably disposed about an inflatable balloon oriented at the distal end of the delivery catheter in the implanting step is comprised of expanding the inflatable balloon.

5 . The method of claim 4 , wherein the prosthetic heart valve is crimped around the inflatable balloon.

6 . The method device of claim 1 , wherein the layer of synthetic biocompatible material is attached about an entire circumference of the expandable support member.

7 . The method of claim 6 , wherein the synthetic biocompatible material is selected from the group consisting of: a polyester, woven velour, polyurethane, PTFE, ePTFE, and heparin-coated fabric.

8 . The method of claim 6 , wherein the layer of biocompatible material comprises interrupted sections.

9 . The method of claim 1 , wherein the animal tissue is selected from the group consisting of: bovine pericardium, equine pericardium, porcine pericardium, peritoneal tissue, and a cell-seeded tissue and combinations thereof.

10 . The method of claim 1 , further comprising a radiographically opaque marking associated with the expandable support member.

11 . The method of claim 1 , further comprising a therapeutic agent associated with the expandable support member.

12 . The method of claim 1 , wherein the expandable support member is comprised of a continuous series of W-shaped segments.

13 . The method of claim 1 , wherein three valve leaflets of the valve component are joined together at three commissural sections that are spaced apart from each other and attached to three strut members to prevent prolapse of the valve leaflets following the implantation step.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded May 16, 2024
From: THE CLEVELAND CLINIC FOUNDATION
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 067429/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2023
From: NAVIA, JOSE LUIS; CHEN, JI-FENG
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 065843/0862 →